Outset Medical, Inc. (OM) Financial Ratios
8 years of historical data (2018–2025) · Healthcare · Medical - Devices
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
0.56
↓-82% vs avg
5yr avg: 3.09
30Y Low0.4·High7.4
ROE
↓
-106.2%
-15% vs avg
5yr avg: -92.2%
30Y Low-171%·High-37%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
OM Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Outset Medical, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $87M | $56M | $58M | $268M | $1.2B | $2.1B | $2.4B | — | — |
| Enterprise Value | $156M | $126M | $136M | $336M | $1.3B | $2.0B | $2.2B | — | — |
| P/E Ratio → | -0.87 | — | — | — | — | — | — | — | — |
| P/S Ratio | 0.73 | 0.47 | 0.51 | 2.06 | 10.78 | 20.48 | 48.63 | — | — |
| P/B Ratio | 0.56 | 0.44 | 2.15 | 2.18 | 5.06 | 5.62 | 7.39 | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
OM EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.05 | 1.19 | 2.58 | 11.04 | 19.07 | 43.50 | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
OM Profitability
Margins and return-on-capital ratios measuring operating efficiency
Outset Medical, Inc. earns an operating margin of -55.8%. Operating margins have expanded from -130.2% to -55.8% over the past 3 years, signaling improving operational efficiency. A negative ROE of -106.2% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 39.1% | 39.1% | 33.9% | 22.2% | 15.5% | 7.4% | -26.1% | -118.1% | -304.7% |
| Operating Margin | -55.8% | -55.8% | -99.7% | -130.2% | -139.6% | -127.2% | -235.2% | -466.3% | -2320.0% |
| Net Profit Margin | -68.3% | -68.3% | -112.6% | -132.5% | -141.2% | -128.6% | -243.3% | -453.0% | -2480.3% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | -106.2% | -106.2% | -171.0% | -93.7% | -52.6% | -37.6% | -37.0% | — | — |
| ROA | -30.2% | -30.2% | -43.4% | -48.4% | -37.7% | -30.4% | -49.4% | -57.0% | -32.9% |
| ROIC | -33.2% | -33.2% | -57.6% | -54.6% | -47.8% | -64.9% | — | — | — |
| ROCE | -29.2% | -29.2% | -46.4% | -56.0% | -42.4% | -33.5% | -54.6% | -68.8% | -33.0% |
OM Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $70M ($105M total debt minus $35M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.82 | 0.82 | 7.53 | 1.11 | 0.42 | 0.10 | 0.12 | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 0.55 | 2.90 | 0.55 | 0.12 | -0.39 | -0.78 | — | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -4.78 | -4.78 | -4.52 | -12.59 | -44.61 | -75.81 | -41.02 | -15.04 | -9.73 |
OM Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Outset Medical, Inc.'s current ratio of 6.67x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 5.40x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 5.26x to 6.67x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.67 | 6.67 | 5.69 | 5.26 | 7.19 | 7.93 | 9.43 | 3.20 | 14.46 |
| Quick Ratio | 5.40 | 5.40 | 4.38 | 4.37 | 6.20 | 7.17 | 8.93 | 3.01 | 14.16 |
| Cash Ratio | 4.49 | 4.49 | 3.50 | 3.68 | 5.53 | 6.57 | 8.58 | 2.81 | 13.98 |
| Asset Turnover | — | 0.45 | 0.41 | 0.42 | 0.29 | 0.22 | 0.12 | 0.17 | 0.01 |
| Inventory Turnover | 1.53 | 1.53 | 1.27 | 2.06 | 1.89 | 2.42 | 3.43 | 7.15 | 2.69 |
| Days Sales Outstanding | — | 86.55 | 114.36 | 92.33 | 88.80 | 91.07 | 47.28 | 94.75 | 197.87 |
OM Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Outset Medical, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $15M | $3M | $3M | $3M | $3M | $3M | $2M | $2M |
Peer Comparison
Compare OM with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 OMYou | $87M | -0.9 | — | — | 39.1% | -55.8% | -106.2% | -33.2% | — |
 DVA | $13B | 20.6 | 9.9 | 9.6 | 27.0% | 14.7% | 46.0% | 10.5% | 5.5 |
 FMS | $12B | 11.0 | 5.9 | 6.0 | 25.6% | 9.3% | 6.5% | 5.6% | 3.3 |
 HCAT | $113M | -0.6 | — | — | 48.7% | -51.7% | -58.3% | -32.9% | — |
 BDX | $56B | 26.3 | 14.7 | 20.8 | 45.4% | 11.8% | 6.5% | 4.3% | 3.8 |
 BAX | $9B | -10.0 | 25.4 | 28.0 | 30.1% | -2.7% | -14.6% | -1.4% | 14.9 |
 RMD | $30B | 21.8 | 15.5 | 18.1 | 59.4% | 32.7% | 25.9% | 22.8% | 0.4 |
 HOLX | $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 |
 MMSI | $4B | 29.3 | 13.1 | 17.2 | 48.7% | 12.2% | 8.7% | 7.2% | 2.8 |
 ITGR | $3B | 30.4 | 13.1 | 28.8 | 23.1% | 11.3% | 6.1% | 5.4% | 4.2 |
 TDOC | $1B | -6.1 | 15.1 | 4.4 | 69.5% | -10.4% | -13.9% | -11.5% | 10.4 |
| Healthcare Median | — | 22.3 | 14.5 | 18.5 | 64.0% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 8 years · Updated daily
See OM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OM vs DVA
Side-by-side business, growth, and profitability comparison vs DaVita Inc..
Start ComparisonOM — Frequently Asked Questions
Quick answers to the most common questions about buying OM stock.
What is Outset Medical, Inc.'s P/E ratio?
Outset Medical, Inc.'s current P/E ratio is -0.9x. This places it at the 50th percentile of its historical range.
What is Outset Medical, Inc.'s ROE?
Outset Medical, Inc.'s return on equity (ROE) is -106.2%. The historical average is -83.0%.
Is OM stock overvalued?
Based on historical data, Outset Medical, Inc. is trading at a P/E of -0.9x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Outset Medical, Inc.'s profit margins?
Outset Medical, Inc. has 39.1% gross margin and -55.8% operating margin.